Ex vivo high resolution magic angle spinning metabolic profiles describe intratumoral histopathological tissue properties in adult human gliomas

Magnetic Resonance in Medicine

Volumn 65, Issue 2, 2011, Pages 320-328

  Croitor Sava, A ^a   Martinez Bisbal, M C ^b   Van Huffel, S ^a   Cerda, J M ^b   Sima, D M ^a   Celda, B ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

ex vivo; high cellularity; histopathological tissue properties; HR MAS; infiltration; necrosis; tumor microheterogeneity

Indexed keywords

BIOMOLECULES; CELL DEATH; DIAGNOSIS; INFILTRATION; METABOLISM; METABOLITES; TUMORS;

EX-VIVO; HIGH CELLULARITY; HR-MAS; MICROHETEROGENEITY; NECROSIS; TISSUE PROPERTIES;

MAGIC ANGLE SPINNING;

CHOLINE; CREATINE; LIPID; N ACETYLASPARTIC ACID;

ARTICLE; BRAIN LEVEL; BRAIN METABOLISM; CANCER CELL; CANCER GRADING; CELL INFILTRATION; CONTROLLED STUDY; EX VIVO STUDY; GLIOMA; HIGH RESOLUTION MAGIC ANGLE SPINNING SPECTROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LIPID BRAIN LEVEL; MAJOR CLINICAL STUDY; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TUMOR NECROSIS;

EID: 79251538098     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22619     Document Type: Article

References (39)

1. 1H NMR spectroscopy. J Neurochem 1995; 64: 1655-1661.
2. 1H magnetic resonance spectroscopy. Magn Res Med 2003; 49: 223-232.
3. 1H MRS and histological analysis. NMR Biomed 2008; 21: 677-685.
4. McKnight TR,. Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism. Semin Oncol 2004; 31: 605-617.
5. Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BC, Mengeot MM, Moser E, Padavic-Shaller KA, Sanders JA, Spraggins TA, Stillman AE, Terwey B, Vogl TJ, Wicklow K, Zimmerman RA,. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996; 84: 449-458.
6. Erb G, Elbayed K, Piotto M, Raya J, Neuville A, Mohr M, Maitrot D, Kehrli P, Namer IJ,. Toward improved grading of malignancy in oligodendrogliomas using metabolomics. Magn Reson Med 2008; 59: 959-965.
7. McKnight TR, Lamborn KR, Love TD, Berger MS, Chang S, Dillon WP, Bollen A, Nelson SJ,. Correlation of magnetic resonance spectroscopic and growth characteristics within grades II and III gliomas. J Neurosurg 2007; 106: 660-666.
8. Cheng LL, Anthony DC, Comite AR, Black PM, Tzika AA, González RG,. Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HR-MAS) proton magnetic resonance spectroscopy. Neuro Oncol 2000; 2: 87-95.
9. Andronesi OC, Blekas KD, Mintzopoulos D, Astrakas L, Black PM, Tzika AA,. Molecular classification of brain tumor biopsies using solid-state magic angle spinning proton magnetic resonance spectroscopy and robust classifiers. Int J Oncol 2008; 33: 1017-1025.
10. Tzika AA, Astrakas L, Cao H, Mintzopoulos D, Andronesi OC, Mindrinos M, Zhang J, Rahme LG, Blekas KD, Likas AC, Galatsanos NP, Carroll RS, Black PM,. Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies. Int J Mol Med 2007; 20: 199-208.
11. 1H HR-MAS and genomic analysis of human tumor biopsies discriminate between high and low grade astrocytomas. NMR Biomed 2009; 22: 629-637.
12. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK,. World health organization classification of tumours of the central nervous system. Lyon: IARC; 2007; ISBN 9283224302.
13. Laudadio T, Mastronardi N, Vanhamme L, Van Hecke P, Van Hufel P,. Improved Lanczos algorithms for blackbox MRS data quantitation. J Magn Res 2002; 157: 292-297.
14. Poullet JB, Martinez-Bisbal MC, Valverde D, Monleon D, Celda B, Arus C, Van Huffel S,. Quantification and classification of high-resolution magic angle spinning data for brain tumor diagnosis. Conf Proc IEEE Eng Med Biol Soc 2007; 2007: 5407-5410.
15. Hartigan JA, Wong MA,. A K-means clustering algorithm. Appl Statistics 1979; 28: 100-108.
16. Cohen J, Cohen P, West SG, Aiken LS,. Applied multiple regression/correlation analysis for the behavioral sciences. Hillsdale, New Jersey, London: Lawrence Erlbaum Associates; 2003.
17. Strehl A,. Relationship-based clustering and cluster ensembles for high-dimensional data mining, PhD thesis, Austin, 2002.
18. Krzanowski J, Lai YT,. A criterion for determing the number of groups in a data set using sum-of-squares clustering. Biometrics 1985; 44: 23-34.
19. Rousseeuw PJ,. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J Comp Appl Math 1987; 20: 53-65.
20. Kaufman L, Rousseeuw PJ,. Finding groups in data: an introduction to cluster analysis. New York: Wiley; 1990
21. Tukey JW,. Comparing individual means in the analysis of variance. Biometrics 1949; 5: 99-114.
22. Hollander M, Wolfe DA,. Nonparametric statistical methods. New York: Wiley; 1973.
23. 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med 1992; 24: 123-136.
24. Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, Di C,. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 1997; 87: 516-524.
25. Gower JC, Hand DJ,. Biplots. London, UK: Chapman & Hall; 1996. ISBN 0412716305.
26. Barba I, Cabañas ME, ArÃs C,. The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells. Cancer Res 1999; 59: 1861-1868.
27. 1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed 1994; 7: 149-155.
28. 1H NMR spectroscopy in vivo and in vitro. J Neurochem 1994; 63: 1538-1543.
29. Podo F,. Tumour phospholipid metabolism. NMR Biomed 1999; 12: 413-439.
30. Tong Z, Yamaki T, Harada K, Houkin K,. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. Magn Reson Imaging 2004; 22: 735-742.
31. 1H MR spectroscopy of brain tumours and masses. Nucl Magn Reson Biomed 2003; 16: 123-131.
32. Stadlbauer A, Gruber S, Nimsky C, Fahlbusch R, Hammen T, Buslei R, Tomandl B, Moser E, Ganslandt O,. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology 2006; 238: 958-969.
33. Majos C, Margarida Julia-Sape M, Alonso J, Serrallonga M, Aguilera C, Acebes JJ, Arus C, Gili, K,. Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE. Am J Neuroradiol 2004; 25: 1696-1704.
34. Opstad KS, Wright AJ, Bell BA, Griffiths JR, Howe FA,. Correlations between in vivo (1) H MRS and ex vivo (1) H HRMAS metabolite measurements in adult human gliomas. J Magn Reson Imaging 31: 289-297.
35. Poullet JB, Sima DM, Van Huffel S,. Metabolite quantification in MRS and pattern recognition. Encyclopedia of magnetic resonance. New York: Wiley; 2009. pp 1-9; Lirias number: 229620.
36. 1H MRS study of human high grade gliomas. NMR Biomed 2004; 17: 191-205.
37. Celda B, Monleõn D, Martínez-Bisbal MC, Esteve V, Martínez-Granados V, Pinero E, Ferrer R, Piquer J, Martí-Bonmati L, Cervera J, Lõpez-Guerrero LA,. New trends in cancer for the 21st century. Adv Exp Med Biol 2006; 587: 285-302.
38. Fan G, Sun B, Wu Z, Guo Q, Guo Y,. In vivo single-voxel protonMR spectroscopy in the differentiation of high-grade gliomas and solitary metastases. Clin Radiol 2004; 59: 77-85.
39. Luts J, Laudadio T, Martinez-Bisbal MC, Van Cauter S, Molla E, Piquer J, Suykens JAK, Himmelreich U, Celda B, Van Huffel S,. Differentiation between brain metastases and glioblastoma multiforme based on MRI, MRS and MRSI. Computer-Based Medical Systems, CBMS, Albuquerque, NM, 2009;1-8. 22nd IEEE International Symposium, 2-5 Aug. 2009.